Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Molecular Psychiatry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1038/sj.mp.4000329PMID 9399689
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT

  2005cited by this paper
• Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia.

  1997cited by this paper
• A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery.

  1996cited by this paper
• Initial human studies with single-photon emission tomography using iodine-123 labelled 3-(5-cyclopropyl-1,2,4-oxadiazo-3-yl)-7-iodo-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]-benzodiazepine (NNC 13-8241)

  1996cited by this paper
• Development of 123I-labelled NNC 13-8241 as a radioligand for SPECT visualization of benzodiazepine receptor binding.

  1996cited by this paper
• Delayed image of iodine-123 iomazenil as a relative map of benzodiazepine receptor binding: The optimal scan time

  1996cited by this paper
• Measurement of pulmonary blood flow by fractal analysis of flow heterogeneity in isolated canine lungs.

  1996cited by this paper
• Fractals and the birth of Gothic: reflections on the biologic basis of creativity.

  1996cited by this paper
• Abnormal regional benzodiazepine receptor uptake in the prefrontal cortex in patients with panic disorder

  1995cited by this paper
• Imaging of serotonin and dopamine transporters in the living human brain

  1995cited by this paper
• Reduced benzodiazepine receptor binding in panic disorders measured by iomazenil SPECT.

  1995cited by this paper
• Benzodiazepine receptor function in anxiety disorders.

  1995cited by this paper
• [11C]Flumazenil Positron Emission Tomography Visualizes Frontal Epileptogenic Regions

  1995cited by this paper
• Physical performance of the Siemens MultiSPECT 3 gamma camera

  1993cited by this paper
• Extinction of emotional learning: contribution of medial prefrontal cortex.

  1993cited by this paper
• Comparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci.

  1993cited by this paper
• Brain perfusion abnormalities in drug-naive, lactate-sensitive panic patients: a SPECT study.

  1993cited by this paper
• The role of the amygdala in fear and anxiety.

  1992cited by this paper
• Emotion and the amygdala.

  1992cited by this paper
• PET in generalized anxiety disorder.

  1991cited by this paper
• Autoradiographic analysis of serotonin 5-HT1A receptor binding in the human brain postmortem: effects of age and alcohol.

  1991cited by this paper
• Cerebral glucose metabolic differences in patients with panic disorder.

  1990cited by this paper
• Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder.

  1990cited by this paper
• Chaos and fractals in human physiology.

  1990cited by this paper
• Physiology in Fractal Dimensions

  1990cited by this paper
• Fractal Nature of Regional Myocardial Blood Flow Heterogeneity

  1989cited by this paper
• In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci.

  1988cited by this paper
• Yohimbine alters regional cerebral blood flow in panic disorder.

  1988cited by this paper
• Physiological Heterogeneity: Fractals Link Determinism and Randomness in Structures and Functions.

  1988cited by this paper
• Cerebral blood flow changes during sodium-lactate-induced panic attacks.

  1988cited by this paper
• Physiological Heterogeneity: Fractals Link Determinism and Randomness in Structures and Functions

  1988cited by this paper
• The assessment of anxiety states by rating.

  1959cited by this paper

• Anxiety Disorder: Measuring the Impact on Major Depressive Disorder

  2025cites this paper
• Neural circuitry of anxiety: evidence from structural and functional neuroimaging studies.

  2025cites this paper
• Impact of Abl2/Arg Deficiency on Anxiety and Depressive Behaviors in mice.

  2024cites this paper
• Advances in neuroscience research and big data's analysis on anxiety disorder.

  2024cites this paper
• GABAergic circuits of the basolateral amygdala and generation of anxiety after traumatic brain injury

  2022cites this paper
• Sleep and anxiety: From mechanisms to interventions.

  2021cites this paper
• PET and SPECT Studies in Anxiety Disorders

  2020cites this paper
• Non-pharmacological and pharmacological approaches for psychiatric disorders: Re-appraisal and insights from zebrafish models.

  2020cites this paper
• Novel investigational therapeutics for generalized anxiety disorder (GAD)

  2019cites this paper
• L-type Ca2+ channels and charybdotoxin-sensitive Ca2+-activated K+ channels are required for reduction of GABAergic activity induced by β2-adrenoceptor in the prefrontal cortex.

  2019cites this paper
• Long-term effects of elevated manganese on procambarus clarkii behavior

  2019cites this paper
• Gender-dependent regulation of anxiety-like behavior by δ subunit-containing GABAA receptor during postnatal development.

  2019cites this paper
• Imaging and Genetic Approaches to Inform Biomarkers for Anxiety Disorders, Obsessive-Compulsive Disorders, and PSTD.

  2018cites this paper
• Biological markers of generalized anxiety disorder

  2017cites this paper
• Efficacité de la stimulation magnétique transcrânienne répétée dans le trouble anxieux généralisé

  2017cites this paper
• To what extent is it possible to dissociate the anxiolytic and sedative/hypnotic properties of GABAA receptors modulators?

  2016cites this paper
• [Evaluation of the therapeutic efficacy and safety of the selective anxiolytic afobazole in generalized anxiety disorder and adjustment disorders: Results of a multicenter randomized comparative study of diazepam].

  2016cites this paper
• GABAA receptor occupancy by subtype selective GABAAα2,3 modulators: PET studies in humans

  2016cites this paper
• Calcium Channels Hippocampus CA1 Region by Modulating L-Type Neurotensin Enhances GABAergic Activity in Rat

  2015cites this paper
• Diagnosis of male depression in the community and its correlation with cortisol and testosterone

  2015cites this paper
• Mind-Body Practices and the Adolescent Brain: Clinical Neuroimaging Studies.

  2015cites this paper
• Effects of acute or chronic administration of novel 3,4-dimethoxyphenylethylamine derivates on anxiety-like behavior.

  2015cites this paper
• Anxiety disorders: Generalized anxiety disorder

  2015cites this paper
• Fractals in the Neurosciences, Part II

  2015cites this paper
• Altered GABA function in Major Depression

  2014cites this paper
• Reduced GABAergic Inhibition in the Basolateral Amygdala and the Development of Anxiety-Like Behaviors after Mild Traumatic Brain Injury

  2014cites this paper
• Effects of seven-day diazepam administration on resting-state functional connectivity in healthy volunteers: a randomized, double-blind study

  2014cites this paper
• Neurotransmission: A Review of PET and SPECT Studies in Anxiety Disorders

  2014cites this paper
• Focus on GABAA receptor function

  2014cites this paper
• Differential gene body methylation and reduced expression of cell adhesion and neurotransmitter receptor genes in adverse maternal environment

  2013cites this paper
• The diagnosis and treatment of generalized anxiety disorder.

  2013cites this paper
• Neuroimaging in anxiety disorders.

  2013cites this paper
• Schizophrenia and Parkinson’s disease: Selected therapeutic advances beyond the dopaminergic etiologies

  2013cites this paper
• Neural Substrates for Heightened Anxiety in Children With Brain Tumors

  2013cites this paper
• Evaluation of the effects of venlafaxine and pregabalin on the carbon dioxide inhalation models of Generalised Anxiety Disorder and panic

  2013cites this paper
• The effect of a clinically effective and non‐effective dose of lorazepam on 7.5% CO2‐induced anxiety

  2012cites this paper
• Generalized anxiety disorder.

  2012cites this paper
• The Role of BERP in Mammalian Systems

  2012cites this paper
• Role of translocator protein (18 kDa) in adult separation anxiety and attachment style in patients with depression.

  2012cites this paper
• Translocator protein as a promising target for novel anxiolytics.

  2012cites this paper
• ROLE OF INHIBITION IN EMOTIONAL LEARNING

  2012cites this paper
• In vivo knockdown of GAD67 in the amygdala disrupts fear extinction and the anxiolytic-like effect of diazepam in mice

  2012cites this paper
• Untitled Page

  2012cites this paper
• The GABAA-BZR complex as target for the development of anxiolytic drugs.

  2012cites this paper
• Deactivation of the parvalbumin-positive interneurons in the hippocampus after fear-like behaviour following electrical stimulation of the dorsolateral periaqueductal gray of rats.

  2012cites this paper
• Anxiety in Parkinson's disease: a critical review of experimental and clinical studies.

  2012cites this paper
• The GABAergic deficit hypothesis of major depressive disorder

  2011cites this paper
• Functional brain imaging: a brief overview of imaging techniques and their use in human and canine anxiety research Angststoornissen: de verschillende technieken van functionele hersenbeeldvorming en de bevindingen bij mens en hond met angststoornissen

  2011cites this paper
• Neurobiology and Genetics of Generalized Anxiety Disorder

  2011cites this paper
• Prodynorphin gene deletion increased anxiety-like behaviours, impaired the anxiolytic effect of bromazepam and altered GABAA receptor subunits gene expression in the amygdala

  2011cites this paper
• Functional brain imaging: a brief overview of imaging techniques and their use in human and canine anxiety research

  2011cites this paper
• Comparação entre clomipramina e fluoxetina para o tratamento de transtornos de ansiedade em crianças e adolescentes

  2010cites this paper
• The pharmacology of anxiety.

  2010cites this paper
• A candidate gene analysis of response to citalopram and escitalopram treatment in patients with Major Depressive Disorder and Generalized Anxiety Disorder

  2010cites this paper
• Cortical GABA, Striatal Dopamine and Midbrain Serotonin as the Key Players in Compulsive and Anxiety Disorders - Results from In Vivo Imaging Studies

  2010cites this paper
• Anxiety - bridging the heart/mind divide

  2010cites this paper
• GABAA‐benzodiazepine receptor availability in smokers and nonsmokers: Relationship to subsyndromal anxiety and depression

  2009cites this paper
• GABAC Receptors in the Lateral Amygdala: A Possible Novel Target for the Treatment of Fear and Anxiety Disorders?

  2009cites this paper
• Neuronal network pharmacodynamics of GABAergic modulation in the human cortex determined using pharmaco‐magnetoencephalography

  2009cites this paper
• An anxiety-like phenotype in mice selectively bred for aggression.

  2009cites this paper
• P1.190 Detection of Lewy body disease in patients with late-onset depression, anxiety and psychotic disorder with myocardial meta-iodobenzylguanidine scintigraphy

  2009cites this paper
• In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders.

  2009cites this paper
• The effects of lorazepam on extrastriatal dopamine D(2/3)-receptors-A double-blind randomized placebo-controlled PET study.

  2009cites this paper
• Neurobiology of repeated transcranial magnetic stimulation in the treatment of anxiety: a critical review

  2009cites this paper
• Glutamatergic and GABAergic modulations of ultrasonic vocalizations during maternal separation distress in mouse pups

  2009cites this paper
• Steroid hormone fluctuations and GABA(A)R plasticity.

  2009cites this paper
• GABA-A receptors and the response to CO(2) inhalation - a translational trans-species model of anxiety?

  2008cites this paper
• A review of basic principles of fractals and their application to pharmacokinetics.

  2008cites this paper
• Anxiety Disorders: Macromolecular Pathways and Interactions

  2008cites this paper
• Chapter 5.4 Principles and findings from human imaging of anxiety disorders

  2008cites this paper
• Anxiety Disorders: Panic, Social Anxiety, and Generalized Anxiety

  2008cites this paper
• Development and Plasticity of The Retinocollicular Projection

  2008cites this paper
• Neurotensin enhances GABAergic activity in rat hippocampus CA1 region by modulating L-type calcium channels.

  2008cites this paper
• Mise à jour sur les considérations pharmacocinétiques, pharmacodynamiques et les interactions médicamenteuses dans le choix d’une benzodiazépine

  2008cites this paper
• The specificity of different selective and non-selective gabaa (partial) agonists in healthy volunteers

  2008cites this paper
• GABA(A)R plasticity during pregnancy: relevance to postpartum depression.

  2008cites this paper
• The specificity of different selective and non-selective gabaa (partial) agonists in healthy volunteers

  2008cites this paper
• Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis

  2008cites this paper
• MOTHER-INFANT TOUCH, NEUROCHEMISTRY, AND POSTPARTUM ANXIETY

  2008cites this paper
• The Human Dimension: How the Prefrontal Cortex Modulates the Subcortical Fear Response

  2007cites this paper
• Role of pregabalin in the treatment of generalized anxiety disorder

  2007cites this paper
• Use of a simulated annealing algorithm to fit compartmental models with an application to fractal pharmacokinetics.

  2007cites this paper
• Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial

  2007cites this paper
• Neurobiology of Anxiety

  2007cites this paper
• Emerging anxiolytics

  2007cites this paper
• Reduced gamma-aminobutyric acid(A)-benzodiazepine binding sites in insular cortex of individuals with panic disorder.

  2007cites this paper
• Reduced (cid:1) -Aminobutyric Acid A –Benzodiazepine Binding Sites in Insular Cortex of Individuals With Panic Disorder

  2007cites this paper
• Generalised anxiety disorder.

  2006cites this paper
• GABAA Receptors in Central Nervous System Disease: Anxiety, Epilepsy, and Insomnia

  2006cites this paper
• Generalized anxiety disorder: A comorbid disease.

  2006cites this paper
• GABAA receptors: subtypes, regional distribution, and function.

  2006cites this paper
• GABAA Receptors : Subtypes , Regional Distribution , and Function

  2006cites this paper
• Biochemistry basis of anxiety

  2006cites this paper
• The effects of early life trauma on the neurochemistry and behaviour of the adult rat

  2006cites this paper
• Etude du rôle des récepteurs GABA dans l'anxiété, la dépression et l'addiction : approche pharmacologique et génétique

  2006cites this paper
• EEG Topography and Tomography (LORETA) in the Classification and Evaluation of the Pharmacodynamics of Psychotropic Drugs

  2006cites this paper
• Overview of Diagnosis and Drug Treatments of Anxiety Disorders

  2005cites this paper
• Pathophysiology and pharmacology of GABA(A) receptors.

  2005cites this paper
• An open-label study of tiagabine as augmentation therapy for anxiety.

  2005cites this paper
• The GABA-benzodiazepine receptor complex: structure, function, and role in anxiety.

  2005cites this paper